Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Tan Sheet

Executive Summary

Hi-Tech OTC sales fall; social media posts prompt FDA warning; FDA warns PruTect Rx about claims; study finds no DMAA in geranium oil; prebiotic recall spreads to Eco Health product; more news In Brief.

You may also be interested in...



Naturopath Marketing Brain Defense Supplement Anticipates Support For Making TBI Claims

Cover Three Nutritional Brain Defense marketer agrees to pull claims suggesting the supplement beverage can protect against traumatic brain injury after a test the firm on DHA submitted as support contained considerably higher levels of the ingredient than included in the product.

Consent Decrees Are Last “Dance” For Supplement GMP Violators

Consent decrees allow time for a firm to make changes with the goal of re-opening, but not without costly updates to systems and equipment and retaining a consultant and attorneys, food and drug attorney Tony Young says.

Consent Decrees Are Last “Dance” For Supplement GMP Violators

Consent decrees allow time for a firm to make changes with the goal of re-opening, but not without costly updates to systems and equipment and retaining a consultant and attorneys, food and drug attorney Tony Young says.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS105960

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel